-
Civil Society Organizations in Brazil fight for better access to Dolutegravir
Brazilian Interdisciplinary AIDS Association (ABIA), along with the Working Group on Intellectual Property (GTPI) of the Brazilian Network for the...
-
Belarus: Civil society pushes for compulsory license as dolutegravir remains overpriced
Positive Movement (PMPlus) in Belarus, one of our partner organizations, is an NGO representing people living with HIV, advocating for...
-
Letter to ViiV Healthcare: No more time to waste – increase access to dolutegravir in Eastern Europe and Central Asia
Dolutegravir is an essential drug in HIV treatment, recommended by the World Health Organization (WHO). Despite the drug being approved...
-
ITPC backs fight against replacement of HIV drug dolutegravir in El Salvador
For more than a month, people living with HIV in El Salvador’s capital city have been surviving a shortage of...
-
The right to health is compulsory: Time for action on dolutegravir – now!
Why Algeria, Azerbaijan, Belarus, Brazil, Bulgaria, China, Colombia, Kazakhstan, Mexico, Romania, Russia, and Turkey must issue compulsory licences on dolutegravir...
-
FAQs for women of childbearing potential and dolutegravir: Key interim considerations
A forum on the risks of preconception dolutegravir exposure has pulled together frequently asked questions (FAQs) designed to help provide...
-
“We want dolutegravir for all, and we want it now.”
Article first published on the Huffington Post here. We’re calling for a compulsory license on a ‘new’ HIV drug to...
-
The Roadmap – Special Edition Report on Dolutegravir
The Initiative for Medicines, Access and Knowledge (I-MAK), has published a special edition ‘Roadmap report’ on dolutegravir. The report provides...
-
A generic version of dolutegravir will be made available in Morocco: A major victory for ITPC-MENA
After several months of intense advocacy by treatment activists, ViiV Healthcare has extended its dolutegravir license to Morocco, meaning more...
-
African treatment advocates call on ViiV Healthcare to unlock access to dolutegravir for North Africa now
On 1 December 2015 in Harare , at the International Conference on AIDS and STIs in Africa (ICASA), treatment advocates...